Fate Therapeutics, Inc. · NASDAQ:FATE
The Vanguard Group reported a 7.64% stake in Fate Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 7.64% stake in Fate Therapeutics, Inc., 8,766,764 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G/A).
- Stake
- 7.64%
- Shares
- 8,766,764
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 7.64% | 8,766,764 |
Source
Related
- Fate Therapeutics, Inc.
- The Vanguard Group
- Fate Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Tahl Cindy · Aug 5, 2026
- Form 4 · Valamehr Bahram · Aug 5, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 8, 2026
- Form 4 · Tahl Cindy · May 21, 2026
- Form 4 · Valamehr Bahram · May 21, 2026